We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Acting FDA Commissioner Lester Crawford confirmed last week that the unveiling of the agency’s highly anticipated overhaul of pharmaceutical GMPs would occur within the next several months.